GCGuilherme Thomé de Carvalho

Guilherme Thomé de Carvalho

*This is an algorithmically generated author record based on publicly available information.

Guilherme Thomé de Carvalho has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Refined Approach for Closing Refractory Macular Holes Using Subretinal BSS Injection

    by Flavio Mac Cord Medina, Guilherme Thome De Carvalho, Bruno Vasconcelos Coimbra

    Purpose: To present a refined technique utilizing subretinal injection of Balanced Salt Solution (BSS) for the closure of refractory macular holes. Methods: This case report details a 70-year-old female patient with a refractory macular hole in the left eye, who underwent pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, gas tamponade, and subretinal injection of BSS. Results: One month postoperatively, optical coherence tomography (OCT) confirmed successful closure of the macular hole, with best-corrected visual acuity (BCVA) improving to 20/100 in the affected eye. At six-month follow-up, the macular hole remained closed, and OCT revealed partial restoration of the ellipsoid zone and external limiting membrane. BCVA was maintained at 20/100. Conclusion: Subretinal BSS injection appears to be an effective technique for closing refractory macular holes, offering a promising option for complex cases.

  • Apresentação atípica da ceratite herpética em lactente

    by Bruno Frujuelli de Melo, Mathias Andre Kunde, Renato Sztern Queiroz, Guilherme Thomé de Carvalho, Annamaria Ciminelli Barbosa, Mario Martins dos Santos Motta

  • Open Access

    Congenital stationary night blindness linked to a CACNA1F gene mutation

    by Flávio Mac Cord Medina, Vitor José Gonçalves Martins, Filipi Bartholazi França, Igor André Telles da Cunha, Guilherme Thomé de Carvalho

    Congenital stationary night blindness encompasses a heterogeneous group of inherited retinal dystrophies characterized by impaired scotopic vision from birth. This article provides a comprehensive overview of congenital stationary night blindness, focusing on its genetic underpinnings, clinical manifestations, and diagnostic approaches, with a specific emphasis on variants in the CACNA1F gene. Through a detailed case report of a 49-year-old male with congenital stationary night blindness attributed to a hemizygous variant in CACNA1F, we illustrate typical clinical presentations and correlate them [...] ABSTRACT Congenital stationary night blindness encompasses a heterogeneous group of inherited retinal dystrophies characterized by impaired scotopic vision from birth. This article provides a comprehensive overview of congenital stationary night blindness, focusing on its genetic underpinnings, clinical manifestations, and diagnostic approaches, with a specific emphasis on variants in the CACNA1F gene. Through a detailed case report of a 49-year-old male with congenital stationary night blindness attributed to a hemizygous variant in CACNA1F, we illustrate typical clinical presentations and correlate them

  • Open Access

    Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study*

    by Guilherme Thomé de Carvalho, Carlos Eduardo Brandão Mello, Kelma Macedo Pohlmann Simões, Mário Martins dos Santos Motta, Max Kopti Fakoury, Bruno Vasconcelos Coimbra, Laura Gomes Nunes Melo, Flávio Mac Cord Medina

    Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised [...] ABSTRACT Objective: To report the frequency of ocular manifestations in patients undergoing direct-acting antiviral therapy and assess treatment safety based on outcomes; to identify demographic variables associated with hepatitis C virus infection; evaluate treatment effectiveness through sustained virological response. Methods: A prospective cohort study was conducted involving chronic hepatitis C patients undergoing direct-acting antiviral therapy. Ophthalmological evaluations were conducted before treatment initiation and upon completion. Patients were advised to return in case of any visual symptoms. Results: The study comprised